PocketECG
Continuous cardiac monitoring system for arrhythmia detection
Device · HybridCompany source
Company profile
About Medicalgorithmics
Medicalgorithmics is a medical technology company focused on developing innovative cardiac monitoring and diagnostic solutions powered by artificial intelligence. The company specializes in remote cardiac monitoring systems that enable continuous heart rhythm analysis and arrhythmia detection. Their technology platform combines advanced algorithms with wearable cardiac monitoring devices to provide comprehensive diagnostic capabilities for healthcare providers and patients. Medicalgorithmics serves cardiologists, hospitals, and healthcare systems with solutions designed to improve cardiac care delivery, enable early detection of heart rhythm abnormalities, and support remote patient monitoring programs. The company's approach integrates proprietary AI algorithms with medical-grade monitoring hardware to deliver accurate, clinically validated cardiac diagnostics that can be deployed across various care settings.
Company description Medicalgorithmics official website
Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Medicalgorithmics?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- arrhythmias
- cardiac rhythm disorders
- heart rhythm abnormalities
Who it serves
- Cardiologists
- Health Systems
- Hospitals
Deployment & integration
Hybrid deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Reliability of resting heart rate measurements in atrial fibrillation.Journal of electrocardiology · Jul 18, 2026
Estimation of atrial fibrillation burden as a function of monitoring time without atrial fibrillation.Heart rhythm · Apr 7, 2026
Association of daily physical activity with pulmonary artery pressure in HFpEF and HFmrEF NYHA class III patients: a pilot trial-feasibility and first results.Clinical research in cardiology : official journal of the German Cardiac Society · Mar 1, 2026
Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography.Nature medicine · Mar 1, 2025
Diagnostic reliability of monitoring for premature atrial and ventricular complexes.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · Aug 3, 2024
Can 24 h of ambulatory ECG be used to triage patients to extended monitoring?Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · Nov 1, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
DeepRhythmAIK253141 · 510k · Dec 11, 2025
DeepRhythmAIK250932 · 510k · May 27, 2025
DeepRhythmAIK241197 · 510k · Dec 4, 2024
DeepRhythmAIK210822 · 510k · Jul 27, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Medicalgorithmics
Recent articles published on Medicalgorithmics's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Cardiology & Cardiovascular Health
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.